Coriandrum Sativum Seeds Improve Memory, Alleviate Anxiety and Depression, and Enhance Sleep Quality in University Students: A Randomized Controlled Trial
NCT ID: NCT05999071
Last Updated: 2023-08-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
86 participants
INTERVENTIONAL
2022-03-01
2022-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of a Botanical Ingredient in Healthy Subjects With Anxiety and Poor Sleep Quality
NCT06154629
Impact of Insomnia Treatment on Brain Responses During Resting-state and Cognitive Tasks
NCT04024787
Exploring CBTi's Dual Effect on Sleep, Diet, & Chrononutrition
NCT06300684
Effect of Atlas Cedarwood Essential Oil Aromatherapy on Sleep Quality Among Patients With Coronary Heart Disease
NCT03830554
The Effect of Cannabidiol in Learning and Memory of Adults
NCT06074172
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Several studies have indicated the positive effects of C. sativum on memory, anxiety, and depression. In a specific study, the aqueous extract derived from the seeds of C. sativum demonstrated significant reductions in monoamine oxidase-B (MAO-B) activity over time, suggesting its primary role in exerting antidepressant-like effects. Another study reported that the administration of C. sativum leaves improved memory performance and hindered the aging process in rats in a dose-dependent manner. Furthermore, it was observed that C. sativum leaves reversed memory impairments induced by scopolamine and diazepam, while also significantly reducing brain cholinesterase activity and serum total cholesterol levels. Another study evaluated the effects of the ethanolic extract of C. sativum seeds on learning in second-generation mice. Although the plant extract did not enhance learning in the short term following training, it did show improvements in long-term learning. Additionally, in an animal model of anxiety, the effects of different doses (10 mg/kg, 25 mg/kg, 50 mg/kg, and 100 mg/kg administered intraperitoneally) of the aqueous extract of C. sativum seeds were evaluated in terms of motor activity and neuromuscular function. In the elevated plus-maze test, the 100 mg/kg dose of the seeds' aqueous extract exhibited anxiolytic effects by increasing the time spent in and the number of entries into the open arms.
Anxiety, depression, and sleep disorders are prevalent among university students, and these conditions can have a considerable impact on their memory function. Consequently, there has been a rise in the use of stimulant drugs among university students as a means to enhance memory performance and attention, despite the fact that such use is unapproved and non-therapeutic which might be associated with several side effects. As a result, there is a growing interest among neuroscience researchers to identify cognitive-enhancing drugs that can be safely used by healthy individuals without adverse effects.
Given the information provided, it is suggested that C. sativum could potentially serve as a memory enhancer for university students. It is considered a preferable option to stimulant drugs due to its safety profile. Additionally, C. sativum may have positive effects on anxiety, depression, and sleep quality. However, it is important to note that the current body of research on the effects of oral C. sativum on the brain and nervous system is limited, and further studies are necessary to fully understand its potential benefits. Thus, this study aims to assess the impact of oral C. sativum on memory performance, anxiety, depression, and sleep quality in university students.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Coriandrum sativum group
500 mg of C. sativum (capsules) were administered twice daily
Coriandrum sativum seeds
Each group consisted of 50 students. In the C. sativum group, dried powdered seeds of C. sativum were administered, while in the control group, starch was provided as a placebo. Both the C. sativum and placebo capsules were identical in shape, color, and outer packaging to maintain the blinding of the participants.
control group
500 mg of starch (capsules) were administered twice daily
Coriandrum sativum seeds
Each group consisted of 50 students. In the C. sativum group, dried powdered seeds of C. sativum were administered, while in the control group, starch was provided as a placebo. Both the C. sativum and placebo capsules were identical in shape, color, and outer packaging to maintain the blinding of the participants.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Coriandrum sativum seeds
Each group consisted of 50 students. In the C. sativum group, dried powdered seeds of C. sativum were administered, while in the control group, starch was provided as a placebo. Both the C. sativum and placebo capsules were identical in shape, color, and outer packaging to maintain the blinding of the participants.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 19-23 of age
Exclusion Criteria
* Psychiatric disorders.
* Using any form of medication (including complementary and alternative medicines).
* Pregnant and lactating individuals.
19 Years
23 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Hashemite University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Abdelrahim Alqudah
Assisstant professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Pharmaceutical Sciences
Zarqa, , Jordan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
21/6/2022/2023
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.